Reversible parkinsonism in systemic lupus erythematosus

Journal of the Neurological Sciences

Volumn 193, Issue 1, 2001, Pages 53-57

  Tan, E K ^a   Chan, L L ^a   Auchus, A P ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

MRI; Parkinsonism; Systemic lupus erythematosus

Indexed keywords

CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; PREDNISOLONE;

ADULT; ARTICLE; BRADYKINESIA; CASE REPORT; FEMALE; GAIT DISORDER; HUMAN; MUSCLE RIGIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONISM; PATHOGENESIS; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

BRAIN; CYCLOPHOSPHAMIDE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; PARKINSONIAN DISORDERS; PREDNISOLONE; TREATMENT OUTCOME;

EID: 0035892522     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(01)00604-9     Document Type: Article

References (20)

1. Systemic lupus erythematosus
2. Neurologic characteristics of childhood lupus erythematosus
3. Neurologic manifestations of systemic lupus erythematosus
4. Parkinsonism as unusual neurologic complication in childhood systemic lupus erythematosus
5. Antidopaminergic antibodies in a patient with complex autoimmune disorder and rapidly progressing Parkinson's disease
6. Parkinson-like symptoms as a manifestation of systemic lupus erythematosus
7. Systemic lupus erythematosus associated with transverse myelitis and parkinsonian symptoms
8. Systemic lupus erythematosus presenting with steroid-responsive parkinsonism and post-hemiplegic dystonia
9. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes
10. Interleukin (IL)-1 beta, IL-2, IL-4, IL-6 and transforming growth factor-alpha levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease
11. Interleukin-6 levels in cerebrospinal fluid inversely correlate to severity of Parkinson's disease
12. Elevated levels of interleukin 6 in cerebrospinal fluid from patients with systemic lupus erythematosus and central nervous system involvement
13. Interleukin 1β, interleukin 6, epidermal growth factor and transforming growth factor-α are elevated in the brain from parkinsonian patients
14. Defective production of interleukin 2 in patients with idiopathic Parkinson's disease
15. Clinical correlates of vascular parkinsonism
16. Lower body (vascular) parkinsonism
17. Lower body parkinsonism: evidence of vascular etiology
18. MRI in patients suspected of vascular parkinsonism
19. Lupus and the nervous system